Compliance certificate as per SEBI (PIT) Regulations, for the quarter ended 31.12.2025.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has filed a compliance certificate with the stock exchanges as required under SEBI's Prohibition of Insider Trading (PIT) Regulations for the quarter ended 31 December 2025. This is a routine quarterly regulatory filing that confirms the company's adherence to insider trading norms, including maintenance of a structured digital database (SDD) of insiders and compliance with trading window restrictions during the quarter. The filing is mandatory under Regulation 7(2) of SEBI PIT Regulations and is submitted by the company's Compliance Officer. No material business or financial information is disclosed in this filing.
This is a routine regulatory compliance filing with no direct impact on the stock price or shareholder value. It reassures investors that the company is following proper governance and insider trading controls.